PMVP PMV Pharmaceuticals Inc

  1. Stocks
  2. Healthcare
  3. NASDAQ: PMVP

Price (delayed)

$1.915

Market cap

$98.51M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$1.44

Enterprise value

$73.27M

PMV Pharma is a precision oncology company pioneering the discovery and development of small molecule, tumor-agnostic therapies targeting p53 mutants. p53 mutations are found in approximately half of all cancers. ...

Highlights
The EPS is up by 11% year-on-year and by 8% since the previous quarter
The company's net income rose by 6% YoY and by 4.9% QoQ
The debt has declined by 4.9% year-on-year but it has increased by 4.6% since the previous quarter
The quick ratio is down by 35% YoY and by 23% QoQ
PMVP's equity is down by 8% year-on-year and by 5% since the previous quarter
Sector: Healthcare
Industry: Biotechnology
Website: http://pmvpharma.com
Peers: OMER OMGA

Key stats

What are the main financial stats of PMVP
Market
Shares outstanding
51.44M
Market cap
$98.51M
Enterprise value
$73.27M
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
0.43
Price to sales (P/S)
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
Earnings
Revenue
$0
EBIT
-$68.96M
EBITDA
-$68.07M
Free cash flow
-$56.62M
Per share
EPS
-$1.44
Free cash flow per share
-$1.18
Book value per share
$4.41
Revenue per share
$0
TBVPS
$5.25
Balance sheet
Total assets
$252.15M
Total liabilities
$26.46M
Debt
$13.29M
Equity
$225.69M
Working capital
$193.38M
Liquidity
Debt to equity
0.06
Current ratio
14.78
Quick ratio
14.53
Net debt/EBITDA
0.37
Margins
EBITDA margin
N/A
Gross margin
N/A
Net margin
N/A
Operating margin
N/A
Efficiency
Return on assets
-27.3%
Return on equity
-30.3%
Return on invested capital
-38.8%
Return on capital employed
-29%
Return on sales
N/A
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

PMVP stock price

How has the PMV Pharmaceuticals stock price performed over time
Intraday
2.41%
1 week
9.43%
1 month
12.65%
1 year
-60.27%
YTD
-38.23%
QTD
12.65%

Financial performance

How have PMV Pharmaceuticals's revenue and profit performed over time
Revenue
$0
Gross profit
$0
Operating income
-$80.13M
Net income
-$68.96M
Gross margin
N/A
Net margin
N/A
The company's net income rose by 6% YoY and by 4.9% QoQ
PMVP's operating income is down by 4% YoY but it is up by 2.7% from the previous quarter

Growth

What is PMV Pharmaceuticals's growth rate over time

Valuation

What is PMV Pharmaceuticals stock price valuation
P/E
N/A
P/B
0.43
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
The EPS is up by 11% year-on-year and by 8% since the previous quarter
PMVP's price to book (P/B) is 62% less than its last 4 quarters average of 1.1
PMVP's equity is down by 8% year-on-year and by 5% since the previous quarter

Efficiency

How efficient is PMV Pharmaceuticals business performance
The company's return on equity fell by 11% YoY but it rose by 2.6% QoQ
PMV Pharmaceuticals's ROIC has increased by 11% from the previous quarter
The return on assets has declined by 9% year-on-year but it has increased by 3.2% since the previous quarter

Dividends

What is PMVP's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for PMVP.

Financial health

How did PMV Pharmaceuticals financials performed over time
The current ratio has contracted by 35% YoY and by 23% from the previous quarter
The quick ratio is down by 35% YoY and by 23% QoQ
The debt is 94% smaller than the equity
The company's debt to equity rose by 20% QoQ
PMVP's equity is down by 8% year-on-year and by 5% since the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.